Abstract: A method and apparatus for initiating secure operations in a microprocessor system is described. In one embodiment, one initiating logical processor initiates the process by halting the execution of the other logical processors, and then loading initialization and secure virtual machine monitor software into memory. The initiating processor then loads the initialization software into secure memory for authentication and execution. The initialization software then authenticates and registers the secure virtual machine monitor software prior to secure system operations.

Abstract: In one embodiment of the present invention, a method includes verifying a master processor of a system; validating a trusted agent with the master processor if the master processor is verified; and launching the trusted agent on a plurality of processors of the system if the trusted agent is validated. After execution of such a trusted agent, a secure kernel may then be launched, in certain embodiments. The system may be a multiprocessor server system having a partially or fully connected topology with arbitrary point-to-point interconnects, for example.

Abstract: The invention provides novel compositions comprising imidazoquinoxaline compounds of formula (I) and analogs thereof. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are novel compositions and methods of administering the compositions in combination with (an) other agent(s).

Abstract: Apparatuses, methods, and systems for reconfiguring a secure system are disclosed. In one embodiment, an apparatus includes a configuration storage location, a lock, and lock override logic. The configuration storage location is to store information to configure the apparatus. The lock is to prevent writes to the configuration storage location. The lock override logic is to allow instructions executed from sub-operating mode code to override the lock.

Abstract: The present invention provides a compound of formula (I): and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided is a method of treating a disease or condition mediated by CDK9.

Abstract: An article of manufacture is provided for securing a region in a memory of a computer. According to one embodiment, the article of manufacture comprises a machine-accessible medium including data that, when accessed by a machine, causes the machine to: halt all but one of a plurality of processing elements in a computer, where the halted processing elements enter into a special halted state; load content into the region only after the halting of all but the one of the plurality of processing elements and the region is protected from access by the halted processing elements; place the non-halted processing element into a known privileged state; and cause the halted processing elements to exit the halted state after the non-halted processing element has been placed into the known privileged state.

Abstract: A method and apparatus is provided for securing a region in a memory of a computer. According to one embodiment, the method comprises halting of all but one of a plurality of processors in a computer. The halted processors entering into a special halted state. Content is loaded into the region only after the halting of all but the one of the plurality of processors and the region is protected from access by the halted processors. The method further comprises placing the non-halted processor into a known privileged state, and causing the halted processors to exit the halted state after the non-halted processor has been placed into the known privileged state.

Abstract: Apparatuses, methods, and systems for reconfiguring a secure system are disclosed. In one embodiment, an apparatus includes a configuration storage location, a lock, and lock override logic. The configuration storage location is to store information to configure the apparatus. The lock is to prevent writes to the configuration storage location. The lock override logic is to allow instructions executed from sub-operating mode code to override the lock.

Abstract: Benzoxazole and benzothiazole compounds and their oxides, esters, prodrugs, solvates, and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent are also disclosed. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF 1R.

Abstract: In one embodiment of the present invention, a method includes verifying a master processor of a system; validating a trusted agent with the master processor if the master processor is verified; and launching the trusted agent on a plurality of processors of the system if the trusted agent is validated. After execution of such a trusted agent, a secure kernel may then be launched, in certain embodiments. The system may be a multiprocessor server system having a partially or fully connected topology with arbitrary point-to-point interconnects, for example.

Abstract: A method and apparatus for initiating secure operations in a microprocessor system is described. In one embodiment, one initiating logical processor initiates the process by halting the execution of the other logical processors, and then loading initialization and secure virtual machine monitor software into memory. The initiating processor then loads the initialization software into secure memory for authentication and execution. The initialization software then authenticates and registers the secure virtual machine monitor software prior to secure system operations.

Abstract: In one embodiment of the present invention, a method includes verifying an initiating logical processor of a system; validating a trusted agent with the initiating logical processor if the initiating logical processor is verified; and launching the trusted agent on a plurality of processors of the system if the trusted agent is validated. After execution of such a trusted agent, a secure kernel may then be launched, in certain embodiments. The system may be a multiprocessor server system having a partially or fully connected topology with arbitrary point-to-point interconnects, for example.

Abstract: The present invention provides a compound of Formula (I): and pharmaceutically acceptable salts thereof. Also provided is a method of using a compound of Formula I for treating a disease or condition mediated by a CDK inhibitor.

Abstract: A method for controlling an output of a AC current fluorescent lamp, including the steps of predetermining a desired degree of lamp illumination, determining the zero crossing point of a waveform representing an input voltage to the fluorescent lamp, and correlating the desired degree of illumination in relation to the zero crossing point and a cycle position later than the zero crossing point. Input voltage is allowed to flow to the fluorescent lamp beginning at zero voltage and an output feedback load is generated by the fluorescent lamp. The optimized input voltage is prevented from flowing to the fluorescent lamp after the zero crossing point at the correlated position of the input current in relation to the zero crossing point based on the detected output feedback load generated by the fluorescent lamp. A dimmer for carrying out the method is also disclosed.

Abstract: A method and apparatus for initiating secure operations in a microprocessor system is described. In one embodiment, one initiating logical processor initiates the process by halting the execution of the other logical processors, and then loading initialization and secure virtual machine monitor software into memory. The initiating processor then loads the initialization software into secure memory for authentication and execution. The initialization software then authenticates and registers the secure virtual machine monitor software prior to secure system operations.

Abstract: The invention provides novel compositions comprising imidazoquinoxaline compounds of formula (I) and analogs thereof. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are novel compositions and methods of administering the compositions in combination with (an) other agent(s).

Abstract: In one embodiment of the present invention, a method includes verifying a master processor of a system; validating a trusted agent with the master processor if the master processor is verified; and launching the trusted agent on a plurality of processors of the system if the trusted agent is validated. After execution of such a trusted agent, a secure kernel may then be launched, in certain embodiments. The system may be a multiprocessor server system having a partially or fully connected topology with arbitrary point-to-point interconnects, for example.

Abstract: A method and system of deadlock free bus protection of memory and I/O resources during secure execution. A bus cycle initiates entry of a bus agent into a secure execution mode. The chipset records an identifier of the secure mode processor. Thereafter, the chipset intercedes if another bus agent attempts a security sensitive bus cycle before the secure mode processor exits the secure mode.

Abstract: The invention provides novel compositions comprising Imidazopyridine compounds. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are novel compositions and methods of administering the compositions in combination with (an)other agent(s).

Abstract: The present invention provides compounds of Formula (I): and pharmaceutically acceptable salts thereof. Also provided is a method of using a compound of Formula I for treating a disease or condition mediated by a CDK inhibitor.